CACNG5
Basic information
Region (hg38): 17:66835117-66894751
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CACNG5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 22 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 22 | 0 | 1 |
Variants in CACNG5
This is a list of pathogenic ClinVar variants found in the CACNG5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-66877389-T-C | Benign (Mar 29, 2018) | |||
17-66877423-G-A | not specified | Uncertain significance (Jan 06, 2023) | ||
17-66877432-C-A | not specified | Uncertain significance (Aug 17, 2022) | ||
17-66877450-G-A | not specified | Uncertain significance (Jun 27, 2022) | ||
17-66877513-G-T | not specified | Uncertain significance (Dec 30, 2023) | ||
17-66877525-G-A | Uncertain significance (Jun 01, 2017) | |||
17-66878981-G-A | not specified | Uncertain significance (Aug 17, 2022) | ||
17-66878981-G-C | not specified | Uncertain significance (Mar 27, 2023) | ||
17-66880565-C-T | not specified | Uncertain significance (Oct 12, 2021) | ||
17-66880634-G-A | not specified | Uncertain significance (Sep 21, 2023) | ||
17-66880643-C-T | not specified | Uncertain significance (May 06, 2022) | ||
17-66880656-C-T | not specified | Uncertain significance (Oct 12, 2022) | ||
17-66884565-T-G | not specified | Uncertain significance (Dec 17, 2023) | ||
17-66884624-C-T | not specified | Uncertain significance (May 18, 2022) | ||
17-66884989-G-A | not specified | Uncertain significance (Jan 22, 2024) | ||
17-66885015-G-T | not specified | Uncertain significance (Dec 02, 2022) | ||
17-66885029-C-A | not specified | Uncertain significance (May 29, 2024) | ||
17-66885062-A-C | not specified | Uncertain significance (Jun 03, 2024) | ||
17-66885062-A-G | not specified | Uncertain significance (Dec 20, 2023) | ||
17-66885065-G-A | not specified | Uncertain significance (Jun 01, 2023) | ||
17-66885070-C-T | not specified | Uncertain significance (Jan 02, 2024) | ||
17-66885071-G-A | not specified | Uncertain significance (Mar 08, 2024) | ||
17-66885088-G-A | not specified | Uncertain significance (Nov 03, 2022) | ||
17-66885164-C-G | not specified | Uncertain significance (Jun 23, 2023) | ||
17-66885220-A-G | not specified | Uncertain significance (Jul 12, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CACNG5 | protein_coding | protein_coding | ENST00000533854 | 5 | 50369 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00612 | 0.915 | 125729 | 0 | 19 | 125748 | 0.0000756 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.241 | 171 | 180 | 0.950 | 0.0000112 | 1801 |
Missense in Polyphen | 52 | 56.066 | 0.92748 | 520 | ||
Synonymous | -0.167 | 79 | 77.1 | 1.02 | 0.00000519 | 550 |
Loss of Function | 1.51 | 5 | 10.2 | 0.490 | 4.32e-7 | 120 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000231 | 0.000231 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000265 | 0.0000264 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000294 | 0.000261 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Regulates the gating properties of AMPA-selective glutamate receptors (AMPARs). Modulates their gating properties by accelerating their rates of activation, deactivation and desensitization. Displays subunit-specific AMPA receptor regulation. Shows specificity for GRIA1, GRIA4 and the long isoform of GRIA2. Thought to stabilize the calcium channel in an inactivated (closed) state (By similarity). {ECO:0000250}.;
- Pathway
- Oxytocin signaling pathway - Homo sapiens (human);Cardiac muscle contraction - Homo sapiens (human);Dilated cardiomyopathy (DCM) - Homo sapiens (human);Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human);Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human);Adrenergic signaling in cardiomyocytes - Homo sapiens (human);MAPK signaling pathway - Homo sapiens (human);Arrhythmogenic Right Ventricular Cardiomyopathy;MAPK Signaling Pathway;GPCR Dopamine D1like receptor;Phase 0 - rapid depolarisation;Phase 2 - plateau phase;Cardiac conduction;Muscle contraction
(Consensus)
Intolerance Scores
- loftool
- 0.269
- rvis_EVS
- -0.14
- rvis_percentile_EVS
- 43.77
Haploinsufficiency Scores
- pHI
- 0.172
- hipred
- N
- hipred_score
- 0.302
- ghis
- 0.461
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.250
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cacng5
- Phenotype
Gene ontology
- Biological process
- transmission of nerve impulse;positive regulation of synaptic transmission, glutamatergic;calcium ion transmembrane transport;neurotransmitter receptor transport, postsynaptic endosome to lysosome;regulation of postsynaptic neurotransmitter receptor activity;postsynaptic neurotransmitter receptor diffusion trapping;neurotransmitter receptor internalization;regulation of AMPA receptor activity
- Cellular component
- plasma membrane;postsynaptic density;cell junction;AMPA glutamate receptor complex;postsynaptic density membrane;glutamatergic synapse;integral component of postsynaptic membrane
- Molecular function
- voltage-gated calcium channel activity;ion transmembrane transporter activity;channel regulator activity